CURE. Funding: How Much Did They Raise & Key Investors

How Much Did CURE. Raise?
Funding & Key Investors

CURE., the Berlin-based pharmacy delivery innovator, has successfully secured a significant capital injection to bolster its market position. With a total funding accumulation of $15M, the company continues to demonstrate robust growth potential within the competitive European healthtech landscape. This latest major strategic investment of $15M underscores investor confidence in the firm's ability to modernize pharmaceutical logistics through its proprietary digital platform.

The infusion of capital arrives at a pivotal moment for the company, which has been scaling its operations since its inception in 2021. By leveraging this financing, CURE. is well-positioned to enhance its delivery infrastructure and expand its footprint in the digital health sector, effectively bridging the gap between traditional pharmacy services and modern consumer expectations for speed and convenience.

What is CURE.?

CURE.

Software

Healthcare Software

Founded in 2021, CURE. operates as a sophisticated pharmacy delivery company and platform provider headquartered in Berlin, Germany. The firm occupies a critical niche in the healthtech ecosystem, focusing on the digitization of pharmaceutical supply chains to ensure rapid, reliable access to medication. By integrating advanced logistics with a user-centric digital interface, CURE. addresses the growing demand for on-demand healthcare services, positioning itself as a key player in the transformation of European retail pharmacy models.

How much funding has CURE. raised?

CURE. has raised a total of $15M across 1 funding round:

2022

Series A

$15M

Series A (2022): $15M with participation from Abstract Ventures, Pi2 Labs, Breega, and J12 Ventures

Key Investors in CURE.

Abstract Ventures

A San Francisco-based venture capital firm managing $1.5 billion in assets, known for its sector-agnostic approach and deep commitment to supporting early-stage founders.

Breega

A European venture capital firm founded by former operators that specializes in scaling startups from pre-Seed to Series A+ across Digital, Climate, and Deep Tech sectors.

J12 Ventures

A thesis-driven venture capital firm that partners with technical founders in Europe to build category-defining companies in the data and AI infrastructure space.

What's next for CURE.?

Looking ahead, the strategic deployment of $15M will likely focus on deepening market penetration within Germany and potentially exploring cross-border expansion. As the company matures, the focus will shift toward optimizing operational efficiency and enhancing the platform's technological capabilities to maintain a competitive edge. The backing from high-profile venture firms suggests a long-term trajectory aimed at category leadership, with potential future developments in AI-driven inventory management and expanded healthcare service offerings. The company remains a focal point for investors interested in the intersection of logistics, digital health, and consumer-facing B2C platforms.

See full CURE. company page

See More Financial Insights